PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-70.17%
Negative net income growth while CRK stands at 7.08%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-6.47%
Both reduce yoy D&A, with CRK at -5.43%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.36%
Negative yoy working capital usage while CRK is 336.13%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.36%
Negative yoy usage while CRK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
150.06%
Some yoy increase while CRK is negative at -251.09%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-2.22%
Negative yoy CFO while CRK is 121.84%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
7.86%
CapEx growth well above CRK's 7.47%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
103.40%
Acquisition growth of 103.40% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1558.05%
Growth well above CRK's 959.33%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
29.17%
Investing outflow well above CRK's 20.93%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-59.85%
Both yoy lines negative, with CRK at -98.74%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.